This webinar takes place on Tuesday April 28 between 16.00 and 16.30 CEST / 15.00-15.30 GMT / 10.00-10.30 AM EDT / 7.00-7.30 AM PDT.

Follow the link to register for the webinar. Please note that the presentation will be given during the live event only and on demand viewing at a later date will not be possible. Contact us for any questions.

 

REGISTER FOR LIVE WEBINAR

 

THIS WEBINAR IS ARRANGED BY CELLECTRICON AB. FOR MORE INFORMATION ON THE HANDLING OF YOUR PERSONAL INFORMATION, SEE OUR PRIVACY POLICY.

Abstract:

Compartmentalized cell cultures, often based on Campenot-style microfluidic systems, provide opportunities to study distinct neurological processes in vitro such as uptake and propagation of misfolded proteins, synaptic transmission and cellular interactions, or axonal degeneration and regeneration. However, many microfluidic compartmentalized devices are low-throughput restricting the integration in drug discovery pipelines.

In this webinar we present a high-capacity microfluidic platform specifically designed for neuroscience drug discovery. By parallelizing up to 96 experiments at a time, this platform provides capacity for efficient drug discovery. We will present the design, development and validation of the platform, as well as several areas of application, including the study of neurite regrowth, axonal transport tracking and synaptic transmission.

Presented by:

Lydia Moll, External Collaborations Manager

Lydia joined the company in 2019 when she started her industrial PhD in Medical Sciences at Karolinska Institutet, Sweden, in collaboration with Cellectricon. Her PhD project was part of BonePain II and focused on the development of high-capacity in vitro assays for chronic pain research. As part of her thesis work, she developed neuronal co-culture models on a microfluidic platform. Lydia is now an External Collaborations Manager at Cellectricon where she designs and drives drug discovery projects for clients in the areas of peripheral neuropathies and neurodegeneration.